Fri.Nov 15, 2024

article thumbnail

Opinion: FDA commissioner: We need action and higher-quality research on ultra-processed foods

STAT

As the saying goes, you are what you eat. And, unfortunately, the food we eat is only solidifying America’s tragic title: We have the lowest life expectancy among large high-income countries. The U.S. Food and Drug Administration is taking a number of steps to help people in the U.S. build healthy diets — including with respect to ultra-processed foods — and the food industry and research community should, too.

FDA 141
article thumbnail

Half of Pharmacy Technicians Feel Fulfilled in Their Current Role

Pharmacy Times

The Connecticut Society of Health-System Pharmacists Technician Committee survey explores the perception of career growth opportunities and challenges.

123
123
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

STAT+: ‘Worst imaginable’ brain tumor yields, in some young people, to CAR-T therapy

STAT

Michelle Monje-Deisseroth says she first treated patients with “the worst imaginable childhood brain tumor” as a medical student about 20 years ago. Diffuse intrinsic pontine gliomas, or DIPG, shackle themselves so insidiously around a young person’s brainstem that no chemo or scalpel can wrest them out. Most children didn’t survive a year.

138
138
article thumbnail

Insights on Innovation: Craig Beavers Previews AHA 2024 and Emerging Trends in Cardiovascular Care

Pharmacy Times

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, CACP will be moderating a session about social determinants of health and heart failure.

125
125
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Community Pharmacists Crucial in RSV Vaccine Education Efforts

Drug Topics

After shared decision making with their community pharmacist, patients were more likely to receive an RSV vaccine.

Vaccines 112
article thumbnail

FDA Grants New Nilotinib Formulation Approval to Treat Adults With Chronic Myeloid Leukemia

Pharmacy Times

The tablets become the first and only nilotinib with no mealtime restrictions indicated for this population.

FDA 112

More Trending

article thumbnail

EMA’s CHMP recommends Sanofi’s Sarclisa approval for multiple myeloma

Pharmaceutical Technology

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of Sanofi’s Sarclisa combined with Velcade, plus Revlimid, plus dexamethasone (VRd) for treating newly diagnosed multiple myeloma (MM).

88
article thumbnail

Drug Shortages are Impacting Patient Care, Pharmacy Resources

Drug Topics

A conversation with Michael Ganio, PharmD, BCPS, FASHP, senior director of Pharmacy Practice and Quality at ASHP.

article thumbnail

Can you drink on Zepbound?

The Checkup by Singlecare

No matter the time of year, there’s always a family get-together, wedding celebration, or festive party just waiting to sabotage your weight loss goals—with delicious treats and alcoholic beverages. If you’re taking Zepbound (tirzepatide), there’s an added layer to consider besides the extra calories: Is it safe to drink while taking this medication?

article thumbnail

STAT+: Up and down the ladder: The latest comings and goings

STAT

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others.  That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.

81
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

FDA Approves Revumenib for the Treatment of Relapsed or Refractory Acute Leukemia

Pharmacy Times

The indication is for adult and pediatric patients 1 year and older with a lysine methyltransferase 2A gene translocation.

FDA 89
article thumbnail

STAT+: Some patients are paying up to $50,000 per year in fees for ‘concierge medicine.’ Here’s what’s behind its rise

STAT

Money can buy lots of stuff. But one of its greatest perks is the ability to make life more frictionless: A first-class airline ticket will expedite you through the airport and onto the plane. An upgraded theme park ticket will allow you to cut to the front of the line. But if you have a  few thousand dollars  to make your trip to Disney World more enjoyable, why not use that money for something far more consequential?

article thumbnail

EU regulators endorse meds from BMS, J&J, Eisai and more—plus a clutch of biosims

Fierce Pharma

In a flurry of activity, Europe’s human medicines committee has done an about-face on Eisai and Biogen’s Alzheimer’s disease med Leqembi, endorsed a clutch of biosimilars, recommended a slew of lab | In a flurry of activity, the European Medicines Agency's CHMP has done an about-face on Eisai and Biogen’s Alzheimer’s disease med Leqembi, endorsed a clutch of biosimilars, recommended a slew of label expansions and put forward new cancer and COVID drugs for approval.

article thumbnail

The Pharmacy Model Is Changing

Pharmacy Times

Embracing artificial intelligence and other tools will be necessary to push the field forward.

94
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Scientists weigh in on RFK Jr. as HHS secretary

STAT

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds.  Sign up here. The schedule at my YMCA recently changed so that my swim workout time now coincides with an Aqua Zumba class. There’s nothing more motivating for a workout than a bunch of ladies chanting/Zumba-ing to the Wobble next to you, and that’s the energy I hope you take into this weekend.

67
article thumbnail

Addressing Payer Coverage Challenges

Pharmacy Times

Panelists discuss how they navigate challenges with payer coverage for quadruplet regimens in multiple myeloma treatment, including strategies they employ to address insurance denials or restrictions, such as providing clinical justification, leveraging recent trial data, and collaborating with financial assistance programs to ensure patients can access optimal therapy despite potential coverage difficulties.

article thumbnail

After US plant reveal, France's Orano Med lays out €250M to build another radioligand facility overseas

Fierce Pharma

With multiple drugmakers already announcing a slew of radiopharmaceutical moves this year, France’s Orano Med is doubling down on the nuclear medicine craze. | Orano Med—developing targeted alpha therapies for cancer—kicked off construction of a 250 million euro plant in the Bessines-sur-Gartempe commune of France. Dubbed the Advanced Thorium Extraction Facility, the new 7,000-square-meter site is slated to manufacture thorium-228, a precursor of lead-212, for radioligand therapies.

59
article thumbnail

Unmet Needs for Transplant-Eligible NDMM

Pharmacy Times

Panelists discuss how pharmacists can address remaining unmet needs and challenges in optimizing frontline therapy for patients with transplant-eligible newly diagnosed multiple myeloma (NDMM), including areas such as managing complex drug interactions, improving medication adherence, mitigating treatment-related toxicities, streamlining transitions of care, and enhancing patient education and support throughout the treatment journey.

65
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Chutes & Ladders—Centene president to retire, Abridge and AccessHope tap industry execs

Fierce Healthcare

Welcome to this week's Chutes & Ladders, our roundup of hirings, firings and retirings throughout the industry. | Welcome to this week's Chutes & Ladders, our roundup of hirings, firings and retirings throughout the industry. Please submit the good news—or the bad—from your shop, and we will feature it here at the end of each week.

58
article thumbnail

Optimizing Self-Management for Outpatient Pharmacy Patients With Diabetes

Pharmacy Times

The use of outpatient pharmacy protocols for glucose testing and insulin administration supplies should be expanded to assist patients in the self-management of diabetes.

65
article thumbnail

Kaufman Hall: Performance stable, but high labor costs challenge hospitals

Fierce Healthcare

Though hospital performance has remained relatively stable, high labor costs continue to challenge hospitals’ bottom line, according to September figures from Kaufman Hall. | Labor expenses from providers accounted for 84% of medical groups’ total expenses. The median subsidy per employed physician was $304,312, rising above $300,000 for the first time.

article thumbnail

FDA Accepts sBLA Review for Dupilumab in Treatment of CSU in Adult and Pediatric Patients

Pharmacy Times

The indication is for patients 12 and older with chronic spontaneous urticaria (CSU) whose disease is not adequately controlled with H1 antihistamine treatment.

FDA 65
article thumbnail

Lecanemab Gets Nod from CHMP for Use in Early Alzheimer’s Disease

BioPharm

Eisai Europe and Biogen have received a positive opinion for the monoclonal antibody therapy to be used as a treatment of adult patients with early Alzheimer’s disease.

59
article thumbnail

Intravenous Immunoglobulin Elicits Favorable Response in Pregnant Patient With Pemphigoid Gestationis

Pharmacy Times

IVIG was found to cease development of new lesions and heal previously documented erosions without adverse events to the patient or fetus.

article thumbnail

STAT+: Mass General doctor reveals cause of death of historic pig kidney transplant patient

STAT

The death  of Rick Slayman,  the first man to receive a kidney transplant from a genetically engineered pig , was caused by an “unexpected cardiac event,” and there was no sign his body was rejecting the organ, his transplant surgeon said Wednesday. The disclosure, six months after the 62-year-old Weymouth, Mass. resident died, was the first public explanation of Slayman’s cause of death and the most detailed confirmation that Slayman’s new kidney was still

article thumbnail

Shingles Vaccine Could Protect Cardiovascular Health

Pharmacy Times

Pharmacists can continue to spread awareness of the importance of receiving a shingles vaccine.

article thumbnail

Blood Sugar, Hashimoto’s, Ozempic, Metformin and Berberine

The Thyroid Pharmacist

One of the lesser-known, but common complications of Hashimoto’s, is blood sugar imbalances. The thyroid gland plays a crucial role in regulating metabolism, and when it is not functioning properly, it can lead to problems with blood sugar control. Blood sugar dysregulation can also be a contributing factor to the development of Hashimoto’s and ongoing symptoms.

article thumbnail

How does prednisone affect your kidneys?

The Checkup by Singlecare

Prednisone is a commonly prescribed steroid , or corticosteroid , medication that can be used in the treatment of many conditions, such as arthritis , allergic reactions, multiple sclerosis (MS), lupus , and certain cancers. It works on the immune system to decrease inflammation (swelling) associated with certain conditions. Prednisone affects many systems in the body, including the kidneys.

Dosage 52
article thumbnail

5 Proven Social Media Marketing Strategies for Pharma Brands

Pharma Marketing Network

In the world of pharmaceutical marketing, social media marketing strategies are more than a trend; they’re a necessity. But with strict regulations and evolving consumer expectations, how do pharma brands navigate the digital landscape effectively? The answer lies in a mix of proven strategies designed for this unique sector. Table of Contents Sr# Headings 1 Know Your Audience and Their Needs 2 Leverage Branded and Unbranded Content 3 Engage Responsibly and Transparently 4 Utilize Influenc

FDA 52
article thumbnail

What is enalapril used for in dogs?

The Checkup by Singlecare

Enalapril is one of the most commonly used prescription medications to treat canine congestive heart failure , kidney disease, or high blood pressure. All are serious, chronic, and progressive conditions. Enalapril treatment improves the dog’s health, slows the progress of these diseases, and lengthens the dog’s life. RELATED: Save up to 80% on enalapril What is enalapril used for in dogs?

Dosage 52
article thumbnail

Pay Per Click Essentials for Pharma Marketing Executives: A Beginner’s Guide

Pharma Marketing Network

In today’s digital-first world, Pay Per Click (PPC) advertising has become an essential strategy for pharma marketing executives. Imagine having a tool that allows you to target specific audiences actively searching for healthcare solutions, like branded medications or treatment options. PPC does just that. But how does it work, and how can you make the most of it in the competitive pharmaceutical industry?

FDA 52
article thumbnail

Melatonin Uses and Benefits

Compounding Pharmacy of America

Melatonin is a natural hormone produced by our bodies. When taken as a supplement, the hormone can deliver important health benefits, like sleep support. The post Melatonin Uses and Benefits appeared first on The Compounding Pharmacy of America.

article thumbnail

Mastering Digital Advertising for Pharma: Strategies That Drive Results

Pharma Marketing Network

The digital landscape has transformed how pharmaceutical brands reach healthcare professionals (HCPs) and patients. Digital advertising is no longer just a nice addition; it’s a must-have for every successful pharma marketing strategy. But how do you make your campaigns stand out in such a highly regulated and competitive industry? Let’s explore some proven strategies that will help you master digital advertising and drive significant results.

52